Latest News
& Press Releases
Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.
TOP STORIES
The FDA’s decision to approve Purdue’s drug Nalmefene earned mixed reactions, especially as the company is in the middle of lawsuits. Here’s what you need to know.
Studies from Guttmacher Institute found that 54% of all abortions in the United States in 2020 were done with pills instead of surgery, an increase from approximately 44% in 2019.
The agreement would have created a spin-off gene therapy company and merged it with ARYA IV to create a new, publicly-traded entity called Caritas Therapies.
Not only is this the first approval for a plant-based vaccine, it’s also the first approval for GSK’s adjuvant.
The researchers note that engineered strains of EcN have been used to diagnose and treat bacterial infections, cancers, gastrointestinal bleeding, inflammatory disorders, and obesity.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
After Judge Denise Cotes banned Martin Shkreli from future involvement in the industry, a second judge handed down a similar order and ordered him to pay a $1.39 million fine.
Moderna, Pfizer and BioNTech and Johnson & Johnson earned an approximate combined revenue of $31 billion in 2021, thanks to the success of their mRNA vaccines against COVID-19.
The new normal may not be particularly new. Although cases appear to be dropping — deaths in the unvaccinated are still high. For that and more COVID-19 stories, continue reading.
There’s always more to learn about Parkinson’s, and researchers discovered a specialized group of neurons associated with the disease.
Biopharma companies are continuously working to test new treatments to the market. Here are three clinical updates announced this week, spanning three different continents.
With two proprietary platforms dedicated to developing tRNA-based therapeutics targeting protein dysfunction, hC Bio aims to develop precision protein editing technology to cure genetic diseases.